Santen - Branded Ophthalmic Portfolio - Ownership and Business Overview

Life ScienceCompany

Santen - Branded Ophthalmic Portfolio Ownership

Who owns Santen - Branded Ophthalmic Portfolio?

Santen - Branded Ophthalmic Portfolio is owned by Harrow. It was acquired on July 18, 2023.

Santen - Branded Ophthalmic Portfolio Business Overview

Where is Santen - Branded Ophthalmic Portfolio headquartered?

Santen - Branded Ophthalmic Portfolio is headquartered in Osaka, Japan.

What sector is Santen - Branded Ophthalmic Portfolio in?

Santen - Branded Ophthalmic Portfolio is a life science company.

Life Science M&A Summary in 2023

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2023. The largest life science acquisition in 2023 was Seagen - which was acquired by Pfizer for $43.0B.

Join Mergr to view all 202 acquisitions of life science companies in 2023, including 25 acquisitions by private equity firms, and 177 by strategics.

Santen - Branded Ophthalmic Portfolio

Santen - Branded Ophthalmic Portfolio

Osaka, 530-8552
Japan,

Santen’s Branded Ophthalmic Portfolio Includes U.S. and Canadian commercial rights to Flarex, natacyn, tobradex st, verkazia, zerviate, and non-prescription brands freshkote and cationorm plus.


Company Summary

SECTOR

Life Science

 Subscribe to unlock this and 207,877
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Santen - Branded Ophthalmic Portfolio

Life Science Companies , Japan Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for Japan Companies

Largest Japan Companies , Acquisitive Japan Companies , Recently Acquired Japan Companies , Recently Sold Japan Companies , Private Japan Companies , Public Japan Companies , Acquired Japan Companies , PE Backed Japan Companies
Mergr

Product

Company

Legal